drugset / Trial / NCT03551080
Inflammation and Brain Function - Pilot Study
Completed
8 enrolled
Karolinska Institutet
Stockholm University · collabSwedish Council for Working Life and Social Research · collabSwedish Heart Lung Foundation · collabThe Swedish Research Council · collabThe Swedish Society of Medicine · collabUniversity of California, San Francisco · collab
RandomizedCrossoverTriple-blindBasic science
Summary
In this randomized double blind cross-over study 8 healthy persons were injected with 0.8 ng/kg body weight lipopolysaccharide (LPS) /endotoxin and placebo at two different occasions. The aim was to investigate how pain sensitivity and health perception change in response to an acute immune activation.
Timeline
- Start
- 2009-10
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lipopolysaccharide | Other / unclassified | 0.8 ng | Intravenous |
Indications
No indication recorded.